Evidence map›Paper›PMID 40276290›Full record

ArticleFarmaceuticos comunitarios2025

[The International Collaboration of Pharmacy Journal Editors (ICPJE) formally constituted to foster quality around clinical and social pharmacy practice research publications].

F Alves Da Costa, F Fernandez-Llimos, S Desselle, I Arnet, Z Babar, Ch Bond, M Cordina, V Garcia Cardenas, M El Hajj, R Jacobsen and 7 more

Abstract readEnglish Abstract
In one paragraph

Article in Farmaceuticos comunitarios, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

F Alves Da CostaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal; International Journal of Clinical Pharmacy, Netherlands.
F Fernandez-LlimosLaboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal; Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Brazil.
S DesselleTouro University California College of Pharmacy, Vallejo, CA, USA; Research in Social and Administrative Pharmacy, USA; Exploratory Research in Clinical and Social Pharmacy, USA.
I ArnetDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Z BabarUniversity of Huddersfield, Huddersfield, UK; Journal of Pharmaceutical Policy and Practice, UK; College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Ch BondUniversity of Aberdeen, Aberdeen, UK; International Journal of Pharmacy Practice, UK.
M CordinaDepartment of Clinical Pharmacology and Therapeutics, WHO Collaborating Centre for Health Professionals Education and Research, University of Malta, Msida, Malta.
V Garcia CardenasResearch in Social and Administrative Pharmacy, USA; University of Granada Faculty of Pharmacy, Granada, Spain.
M El HajjExploratory Research in Clinical and Social Pharmacy, USA; College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
R JacobsenExploratory Research in Clinical and Social Pharmacy, USA; Department of Pharmacy, University of Copenhagen, Denmark.
A W LawResearch in Social and Administrative Pharmacy, USA; Western University of Health Sciences, Pomona, CA, USA.
L S NørgaardResearch in Social and Administrative Pharmacy, USA; Department of Pharmacy, University of Copenhagen, Denmark.
C PolidoriExperimental Medicine and Public Health, University of Camerino, Camerino, Italy; European Journal of Hospital Pharmacy, UK.
N ShcherbakovaWestern New England University, Springfield, MA, USA.
D StewartInternational Journal of Clinical Pharmacy, UK.
F S ToninExploratory Research in Clinical and Social Pharmacy, USA; ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa), Lisbon, Portugal.
A E WeidmannEuropean Journal of Hospital Pharmacy, UK; Faculty for Chemistry and Pharmacy, University of Innsbruck, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resumen: The Granada statements were a result of the need to strengthen clinical, social and administrative pharmacy practice as an area of knowledge that translates into practice, research and policy. As a re-sponse, a group of clinical and social pharmacy practice journal editors launched an initiative in Grana-da in 2022 to discuss ways to improve the quality of publications in this area, which culminated in the Granada statements. Eighteen statements were developed, clustered into six main domains:1) the ap-propriate use of terminology; 2) developing impactful abstracts; 3) having the required peer reviews; 4) preventing journal scattering; 5) more effective and wiser use of journal and article performance met-rics; and 6) authors' selection of the most appropriate pharmacy practice journal to submit their work.The full Granada statements have been published in 14 journals.(1-14) These pioneering statements are rooted in similar endeavors undertaken by scholars in other health professions groups, fostering the concept of interdisciplinary consensus and advancing scientific paradigm.

Indexed as

Periodicals as TopicPharmacyPharmacy ResearchPublishingEditorial PoliciesHumansInternational CooperationInternational Collaboration of Pharmacy Journal Editors (ICPJE)

Identifiers

PMID40276290
PMCPMC12020980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.